Article
Molecular Therapeutics in Development to Treat Alzheimer’s Disease
24 Sept 2024
Abstract excerpt
Until recently, only symptomatic therapies, in the form of acetylcholine esterase inhibitors and NMDA-receptor antagonists, have been available for the treatment of Alzheimer's disease. However, advancements in our understanding of the amyloid cascade hypothesis have led to a development of disease-modifying therapeutic strategies. These include immunotherapies based on an infusion of monoclonal antibodies...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
